Literature DB >> 26064297

Association of microstructural and mechanical properties of cancellous bone and their fracture risk assessment tool scores.

Dengke Wu1, Xin Li2, Cheng Tao3, Ruchun Dai2, Jiangdong Ni3, Eryuan Liao2.   

Abstract

This study is to investigate the association between fracture probabilities determined by using the fracture risk assessment tool (FRAX) and the microstructure and mechanical properties of femoral bone trabecula in osteoporosis (OP) and osteoarthritis (OA) patients with hip replacements. By using FRAX, we evaluated fracture risks of the 102 patients with bone replacements. Using micro CT scanning, we obtained the analysis parameters of microstructural properties of cancellous bone. Through morphometric observations, fatigue tests and compression tests, we obtained parameters of mechanical properties of cancellous bones. Relevant Pearson analysis was performed to investigate the association between the fracture probability and the microstructure and mechanical properties of femoral bone trabecula in patients. Fifteen risk factors in FRAX were compared between OP and OA patients. FRAX hip fracture risk score and major osteoporotic in OP and OA patients were significantly different. FRAX was associated with tissue bone mineral density and volumetric bone mineral density. Our study suggests that the probabilities of major osteoporotic and hip fracture using FRAX is associated with bone mass but not with micro bone quality.

Entities:  

Keywords:  Microstructural; cancellous bone; fracture risk assessment

Year:  2015        PMID: 26064297      PMCID: PMC4443131     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  41 in total

1.  Effects of projective bone area size of the spine on bone density and the diagnosis of osteoporosis in healthy pre-menopausal women in China.

Authors:  X-P Wu; E-Y Liao; R-C Dai; X-H Luo; H Zhang
Journal:  Br J Radiol       Date:  2003-07       Impact factor: 3.039

Review 2.  Role of bone turnover in microdamage.

Authors:  Mitchell B Schaffler
Journal:  Osteoporos Int       Date:  2003-08-29       Impact factor: 4.507

Review 3.  Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis.

Authors: 
Journal:  Am J Med       Date:  1993-06       Impact factor: 4.965

4.  Intrinsic bone tissue properties in adult rat vertebrae: modulation by dietary protein.

Authors:  Stefan Hengsberger; Patrick Ammann; Brian Legros; René Rizzoli; Philippe Zysset
Journal:  Bone       Date:  2004-11-24       Impact factor: 4.398

5.  Sex differences of human trabecular bone microstructure in aging are site-dependent.

Authors:  Felix Eckstein; Maiko Matsuura; Volker Kuhn; Mathias Priemel; Ralph Müller; Thomas M Link; Eva-Maria Lochmüller
Journal:  J Bone Miner Res       Date:  2007-06       Impact factor: 6.741

6.  FRAX and the assessment of fracture probability in men and women from the UK.

Authors:  J A Kanis; O Johnell; A Oden; H Johansson; E McCloskey
Journal:  Osteoporos Int       Date:  2008-02-22       Impact factor: 4.507

7.  Regional variations of vertebral trabecular bone microstructure with age and gender.

Authors:  H Chen; S Shoumura; S Emura; Y Bunai
Journal:  Osteoporos Int       Date:  2008-03-11       Impact factor: 4.507

8.  Age-related differences between thinning of horizontal and vertical trabeculae in human lumbar bone as assessed by a new computerized method.

Authors:  J S Thomsen; E N Ebbesen; L I Mosekilde
Journal:  Bone       Date:  2002-07       Impact factor: 4.398

9.  Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures.

Authors:  D Marshall; O Johnell; H Wedel
Journal:  BMJ       Date:  1996-05-18

10.  Glucocorticoids act directly on osteoblasts and osteocytes to induce their apoptosis and reduce bone formation and strength.

Authors:  Charles A O'Brien; Dan Jia; Lilian I Plotkin; Teresita Bellido; Cara C Powers; Scott A Stewart; Stavros C Manolagas; Robert S Weinstein
Journal:  Endocrinology       Date:  2003-12-22       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.